ÂÜÀòÂÒÂ×

Kiren L. Naidoo is an accomplished executive with extensive experience in the pharmaceutical and financial sectors. Currently serving as the Chief Executive Officer at Zdravlje Leskovac since April 2021, Naidoo also co-founded and holds the position of Managing Director at Frontier Pharma, where expertise in pharmaceutical investments spans Europe, the Middle East, and Africa. Formerly a Vice President at Merrill Lynch from February 2007 to January 2016, Naidoo specialized in healthcare investment banking, contributing to significant M&A and capital markets transactions totaling billions in value. Educational background includes a Bachelor of Business Science in Finance from the University of Cape Town.